"Designing Growth Strategies is in our DNA"

Lab-based IVD Market Size, Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics [Enzyme-Linked Immunosorbent Assay, Fluorescence Immunoassay, Rapid Test], Clinical Chemistry [Electrolyte Panel, Basic & Comprehensive Metabolic Panels, Liver Tests], Molecular Diagnostics [PCR, In Situ Hybridization], Hematology), By Sample Type (Blood, Urine, Saliva, Tissue), By Application (Infectious Diseases, Cardiology, Oncology), By End-user (Hospitals, Clinical Laboratories), & Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI112985

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, by Key Countries/Sub-regions, 2025/2026
    2. Technological Advancements in Lab-based IVD Products
    3. New Product Launches, by Key Players
    4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  5. Global Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By County/ Sub-region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2026)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      2. Abbott
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      3. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      4. Sysmex Corporation
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      5. Siemens Healthineers AG
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      6. BD
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      7. QIAGEN
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      8. Bio-Rad Laboratories, Inc.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      9. Seegene Inc.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      10. DiaSorin S.p.A.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      11. Quest Diagnostics Incorporated
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, by Key Countries/Sub-regions, 2025/2026
    2. Technological Advancements in Lab-based IVD Products
    3. New Product Launches, by Key Players
    4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  5. Global Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By County/ Sub-region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Lab-based IVD Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Consumables
    2. Market Analysis, Insights and Forecast – By Technique
      1. Immunodiagnostics
        1. Enzyme-Linked Immunosorbent Assay (ELISA)
        2. Fluorescence immunoassay (FIA)
        3. Rapid test
        4. Others
      2. Clinical Chemistry
        1. Electrolyte Panel
        2. Basic and Comprehensive Metabolic Panels
        3. Liver Tests
        4. Renal Tests
        5. Lipid Panel
        6. Others
      3. Molecular Diagnostics
        1. Polymerase Chain Reaction (PCR)
        2. In Situ Hybridization
        3. DNA Sequencing & Next-Generation Sequencing
        4. Others
      4. Hematology
      5. Others
    3. Market Analysis, Insights and Forecast – By Sample Type
      1. Blood
      2. Urine
      3. Saliva
      4. Tissue
      5. Others
    4. Market Analysis, Insights and Forecast – By Application
      1. Infectious Diseases
      2. Cardiology
      3. Oncology
      4. Gastroenterology
      5. Allergy
      6. Autoimmunity
      7. Prenatal Screening
      8. Others
    5. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Clinical Laboratories
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2026)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      2. Abbott
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      3. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      4. Sysmex Corporation
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      5. Siemens Healthineers AG
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      6. BD
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      7. QIAGEN
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      8. Bio-Rad Laboratories, Inc.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      9. Seegene Inc.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      10. DiaSorin S.p.A.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      11. Quest Diagnostics Incorporated
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
Read Less

Figure 1: Global Lab-based IVD Market Revenue Breakdown (USD billion, %) by Region, 2026 & 2034

Figure 2: Global Lab-based IVD Market Value Share (%), by Product Type, 2026 & 2034

Figure 3: Global Lab-based IVD Market Value Share (%), by Technique, 2026 & 2034

Figure 4: Global Lab-based IVD Market Value Share (%), by Sample Type 2026 & 2034

Figure 5: Global Lab-based IVD Market Value Share (%), by Application, 2026 & 2034

Figure 6: Global Lab-based IVD Market Value Share (%), by End-user, 2026 & 2034

Figure 7: Global Lab-based IVD Market Value (USD billion), by Region, 2026 & 2034

Figure 8: North America Lab-based IVD Market Value (USD billion), by Product Type, 2026 & 2034

Figure 9: North America Lab-based IVD Market Value Share (%), by Product Type, 2026

Figure 10: North America Lab-based IVD Market Value (USD billion), by Technique, 2026 & 2034

Figure 11: North America Lab-based IVD Market Value Share (%), by Technique, 2026

Figure 12: North America Lab-based IVD Market Value (USD billion), by Sample Type, 2026 & 2034

Figure 13: North America Lab-based IVD Market Value Share (%), by Sample Type, 2026

Figure 14: North America Lab-based IVD Market Value (USD billion), by Application, 2026 & 2034

Figure 15: North America Lab-based IVD Market Value Share (%), by Application, 2026

Figure 16: North America Lab-based IVD Market Value (USD billion), by End-user, 2026 & 2034

Figure 17: North America Lab-based IVD Market Value Share (%), by End-user, 2026

Figure 18: North America Lab-based IVD Market Value (USD billion), By Country, 2026 & 2034

Figure 19: North America Lab-based IVD Market Value Share (%), By Country, 2026

Figure 20: Europe Lab-based IVD Market Value (USD billion), by Product Type, 2026 & 2034

Figure 21: Europe Lab-based IVD Market Value Share (%), by Product Type, 2026

Figure 22: Europe Lab-based IVD Market Value (USD billion), by Technique, 2026 & 2034

Figure 23: Europe Lab-based IVD Market Value Share (%), by Technique, 2026

Figure 24: Europe Lab-based IVD Market Value (USD billion), by Sample Type, 2026 & 2034

Figure 25: Europe Lab-based IVD Market Value Share (%), by Sample Type, 2026

Figure 26: Europe Lab-based IVD Market Value (USD billion), by Application, 2026 & 2034

Figure 27: Europe Lab-based IVD Market Value Share (%), by Application, 2026

Figure 28: Europe Lab-based IVD Market Value (USD billion), by End-user, 2026 & 2034

Figure 29: Europe Lab-based IVD Market Value Share (%), by End-user, 2026

Figure 30: Europe Lab-based IVD Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 31: Europe Lab-based IVD Market Value Share (%), By Country/ Sub-region, 2026

Figure 32: Asia Pacific Lab-based IVD Market Value (USD billion), by Product Type, 2026 & 2034

Figure 33: Asia Pacific Lab-based IVD Market Value Share (%), by Product Type, 2026

Figure 34: Asia Pacific Lab-based IVD Market Value (USD billion), by Technique, 2026 & 2034

Figure 35: Asia Pacific Lab-based IVD Market Value Share (%), by Technique, 2026

Figure 36: Asia Pacific Lab-based IVD Market Value (USD billion), by Sample Type, 2026 & 2034

Figure 37: Asia Pacific Lab-based IVD Market Value Share (%), by Sample Type, 2026

Figure 38: Asia Pacific Lab-based IVD Market Value (USD billion), by Application, 2026 & 2034

Figure 39: Asia Pacific Lab-based IVD Market Value Share (%), by Application, 2026

Figure 40: Asia Pacific Lab-based IVD Market Value (USD billion), by End-user, 2026 & 2034

Figure 41: Asia Pacific Lab-based IVD Market Value Share (%), by End-user, 2026

Figure 42: Asia Pacific Lab-based IVD Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 43: Asia Pacific Lab-based IVD Market Value Share (%), By Country/ Sub-region, 2026

Figure 44: Latin America Lab-based IVD Market Value (USD billion), by Product Type, 2026 & 2034

Figure 45: Latin America Lab-based IVD Market Value Share (%), by Product Type, 2026

Figure 46: Latin America Lab-based IVD Market Value (USD billion), by Technique, 2026 & 2034

Figure 47: Latin America Lab-based IVD Market Value Share (%), by Technique, 2026

Figure 48: Latin America Lab-based IVD Market Value (USD billion), by Sample Type, 2026 & 2034

Figure 49: Latin America Lab-based IVD Market Value Share (%), by Sample Type, 2026

Figure 50: Latin America Lab-based IVD Market Value (USD billion), by Application, 2026 & 2034

Figure 51: Latin America Lab-based IVD Market Value Share (%), by Application, 2026

Figure 52: Latin America Lab-based IVD Market Value (USD billion), by End-user, 2026 & 2034

Figure 53: Latin America Lab-based IVD Market Value Share (%), by End-user, 2026

Figure 54: Latin America Lab-based IVD Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 55: Latin America Lab-based IVD Market Value Share (%), By Country/ Sub-region, 2026

Figure 56: Middle East & Africa Lab-based IVD Market Value (USD billion), by Product Type, 2026 & 2034

Figure 57: Middle East & Africa Lab-based IVD Market Value Share (%), by Product Type, 2026

Figure 58: Middle East & Africa Lab-based IVD Market Value (USD billion), by Technique, 2026 & 2034

Figure 59: Middle East & Africa Lab-based IVD Market Value Share (%), by Technique, 2026

Figure 60: Middle East & Africa Lab-based IVD Market Value (USD billion), by Sample Type, 2026 & 2034

Figure 61: Middle East & Africa Lab-based IVD Market Value Share (%), by Sample Type, 2026

Figure 62: Middle East & Africa Lab-based IVD Market Value (USD billion), by Application, 2026 & 2034

Figure 63: Middle East & Africa Lab-based IVD Market Value Share (%), by Application, 2026

Figure 64: Middle East & Africa Lab-based IVD Market Value (USD billion), by End-user, 2026 & 2034

Figure 65: Middle East & Africa Lab-based IVD Market Value Share (%), by End-user, 2026

Figure 66: Middle East & Africa Lab-based IVD Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 67: Middle East & Africa Lab-based IVD Market Value Share (%), By Country/ Sub-region, 2026

Figure 68: Global Lab-based IVD Market Share (%), By Company, 2026

Table 1: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 2: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 3: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 4: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 5: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 6: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 7: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 8: Global Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2021–2034

Table 9: Global Lab-based IVD Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 10: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 11: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 12: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 13: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 14: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 15: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 16: North America Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 17: North America Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 18: North America Lab-based IVD Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 19: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 20: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 21: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 22: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 23: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 24: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 25: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 26: Europe Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 27: Europe Lab-based IVD Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 28: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 29: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 30: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 31: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 32: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 33: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 34: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 35: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 36: Asia Pacific Lab-based IVD Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 37: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 38: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 39: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 40: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 41: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 42: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 43: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 44: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 45: Latin America Lab-based IVD Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 46: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 47: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Technique, 2021–2034

Table 48: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Immunodiagnostics, 2021–2034

Table 49: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Clinical Chemistry, 2021–2034

Table 50: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2021–2034

Table 51: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 52: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by Application, 2021-2034

Table 53: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, by End-user, 2021-2034

Table 54: Middle East & Africa Lab-based IVD Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Lab-based IVD Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 140
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports